Emerging technologies for the clinical microbiology laboratory.
about
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyVFDB 2016: hierarchical and refined dataset for big data analysis--10 years onExploiting Bacterial Whole-Genome Sequencing Data for Evaluation of Diagnostic Assays: Campylobacter Species Identification as a Case StudyNew and developing diagnostic technologies for urinary tract infections.Current and emerging techniques for antibiotic susceptibility testsThe bacteriology of hidradenitis suppurativa: a systematic review.Optical scatter patterns facilitate rapid differentiation of Enterobacteriaceae on CHROMagar™ Orientation medium.Mass fingerprint analysis of spider mites (Acari) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid discrimination.Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.Identification of Molds by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryEvaluating and Improving Vitek MS for Identification of Clinically Relevant Species of Trichosporon and the Closely Related Genera Cutaneotrichosporon and Apiotrichum.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Amplicon Competition Enables End-Point Quantitation of Nucleic Acids Following Isothermal Amplification.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.Emerging commercial molecular tests for the diagnosis of bloodstream infection.Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics.Mortality, intensive care treatment, and cost evaluation: Role of a polymerase chain reaction assay in patients with sepsis.The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls.The role of the NxTAG® respiratory pathogen panel assay and other multiplex platforms in clinical practice.Powerful qPCR assays for the early detection of latent invaders: interdisciplinary approaches in clinical cancer research and plant pathology.Terahertz spectroscopy for bacterial detection: opportunities and challenges.Rapid and label-free detection and assessment of bacteria by terahertz time-domain spectroscopy.Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant Enterobacteriaceae: a focus on ß-lactam resistance.Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship ProgramsReadXplorer 2-detailed read mapping analysis and visualization from one single source.Addressing the key communication barriers between microbiology laboratories and clinical units: a qualitative study.Reliable Detection of Group B Streptococcus in the Clinical Laboratory.Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS.Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.Intraocular Detection of Herpesviruses by xTAG Liquid Chip Technology in Patients with Acute Retinal Necrosis.Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing.Validation of a novel automatic deposition of bacteria and yeasts on MALDI target for MALDI-TOF MS-based identification using MALDI Colonyst robot.Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.Profile of GenMark's ePlex® blood culture identification fungal pathogen panel.How to manage Pseudomonas aeruginosa infections.Simultaneous Detection of Key Bacterial Pathogens Related to Pneumonia and Meningitis Using Multiplex PCR Coupled With Mass Spectrometry.Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease EpidemiologyEnhanced Recovery of Fastidious Organisms from Urine Culture in the Setting of Total Laboratory Automation
P2860
Q26775404-463B40B2-74EB-467A-8596-7D486E1B0DABQ31025236-3803D5A4-82A9-49CA-8630-303DBD233C02Q31136293-51775F15-77F8-4E21-83EE-DB97BC31DCB9Q33806235-B384F31A-3E99-40B8-A852-4B82D7621FA5Q33820956-74550DA0-622A-42B8-933D-3114603AE848Q35676683-0391E1FD-785B-4699-8349-BF814A65B06DQ35821893-2536F667-CEBB-45ED-99F9-4E71231C9F9AQ35966027-F37E3064-9AB5-4170-A7BF-D6D82FDFF0A7Q36090076-839573BB-EEFB-48E7-8FC3-D8DCBA1F1A77Q36180756-D5C60B66-2901-4FE5-987C-29CFAB59CA1BQ36379419-FA27E279-9FAC-439C-A6AE-CFA7B0D2ED0DQ36630989-A4D4F916-767A-4D74-8397-498C7E901E2BQ38370222-2647B226-848E-4AE9-91B8-9D8650A94A3EQ38384662-24329CB9-AF93-44B6-966A-8742710008B7Q38417636-BBDEEA41-8580-43F4-8E45-C4E6FC17EA6CQ38664738-8AEF9D53-EC51-41D1-BB33-D5022B05FC18Q38668435-B5D2AC41-9476-4349-867F-0B84F6AC19B6Q38766706-4667C6F5-1A65-465D-8429-ACF0399D9116Q38789297-C02E0960-283F-4A3D-BE1A-C2902A0424BCQ38816994-34C73E77-85FF-4A13-A7C0-2BE192846DBBQ38821787-96CDF0FB-B853-49A2-9C06-986CFA974A7CQ38906509-85D10405-4C04-491F-AB81-C7581C8FAACDQ39109739-2C8308C6-BF9A-4C8B-9749-023436AD3592Q39274504-F8A01F8F-B1AF-4B68-8C95-1E30716B9775Q39331856-1F26840A-C2EB-4C7D-9FD5-DAFB926B38F7Q39386435-DEE7D582-D549-44A6-B204-4242666136E5Q39403220-372373DC-5BDA-47DB-A332-6C356523297AQ39513539-71138224-22CB-4A61-B10C-B4E2C669425DQ40405425-B534268F-452E-4A24-BE66-B72CC08ECCBCQ41928248-EFF302D6-D230-46C4-A35B-FCC75D97E8F1Q42104058-9C579C60-8C0D-420D-B090-009954B22965Q46655216-46849CD9-6CC6-416A-84DA-E31DCF29DA5CQ47234065-7F340973-FEE3-4E11-B29F-05CD1F7A418BQ49425859-4142A86C-8B48-4EFF-A434-84C627216A6DQ49638608-E64AA4B9-01C8-45D8-98B4-D2BA6D4C163AQ50128355-62C12772-4D95-442A-81A5-962A3FBFF307Q54977074-82AD24A7-0B0D-4A27-B427-6D90EE39C521Q55037949-9312611A-F3E2-45E5-A803-3194869E9025Q56536622-E5A24B4A-8090-4602-8BC1-A79958D4E86EQ57980714-F2B42AAA-BDDA-4C0A-B527-AEA20CB079C7
P2860
Emerging technologies for the clinical microbiology laboratory.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging technologies for the clinical microbiology laboratory.
@ast
Emerging technologies for the clinical microbiology laboratory.
@en
Emerging technologies for the clinical microbiology laboratory.
@nl
type
label
Emerging technologies for the clinical microbiology laboratory.
@ast
Emerging technologies for the clinical microbiology laboratory.
@en
Emerging technologies for the clinical microbiology laboratory.
@nl
prefLabel
Emerging technologies for the clinical microbiology laboratory.
@ast
Emerging technologies for the clinical microbiology laboratory.
@en
Emerging technologies for the clinical microbiology laboratory.
@nl
P2860
P356
P1476
Emerging technologies for the clinical microbiology laboratory
@en
P2093
Nathan A Ledeboer
P2860
P304
P356
10.1128/CMR.00003-14
P407
P577
2014-10-01T00:00:00Z